In Memoriam

In memoriam: Lucy Chang and Fred Bollum

ASBMB Today Staff
Jan. 15, 2024

Lucy Chang and Fred Bollum, personal and professional partners for more than four decades and longtime members of the American Society for Biochemistry and Molecular Biology, both died in the past year; Bollum on March 2 and Chang on Nov. 13.  Bollum was 95, and Chang was 81.

Frederick James Bollum was born June 14, 1927, in Ellsworth, Wisconsin, the son of Frederick Edward and Helen (Bucholtz) Bollum. He started college at the University of Minnesota as a zoology major and graduated in 1956 with a Ph.D. in physiological chemistry. He conducted a U.S. Public Health Service postdoctoral fellowship at the University of Wisconsin. He then worked at the Oak Ridge National Laboratory, as a biochemistry professor at the University of Kentucky Medical School, and as chair and professor of biochemistry at the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

Lucy Ming Shih Chang was born August 20, 1942, in China, to Timothy Y.N. Chang and Florence I.C. Chang. She earned a B.S. in chemistry at Case Western Reserve University in 1964 and a Ph.D. in biochemistry from Indiana University in 1968; she then pursued postdoctoral research at the University of Kentucky. She began her independent research career the University of Connecticut before serving as professor and department chair at USUHS.

Bollum joined the ASBMB in 1961, and Chang joined in 1974. Bollum was a member of the Journal of Biological Chemistry editorial board in the mid-1960s. During their joint research career, they conducted seminal work on DNA polymerases and discovered the mammalian terminal deoxynucleotidyl transferase, or TdT, a specialized DNA polymerase expressed in precancerous cells and acute leukemia and lymphoma cells.

PDB
Lucy Chang and Fred Bollum built a business around their discovery of the mammalian terminal deoxynucleotidyl transferase, or TdT.

In 1982, Bollum and Chang founded Supertechs, Inc., a biotechnology firm in Rockville, Maryland, specializing in diagnostics for leukemia and apoptosis research. They worked to produce and market monospecific antibodies to TdT. Certain cancerous cells express abnormal concentrations of TdT, making high levels of TdT-positive cells in blood and bone marrow a symptom of disease. Together, Bollum and Chang developed numerous patents related to TdT and other related enzymes.

Bollum’s many interests included music (clarinet and guitar), radio-controlled plane and boat models, astronomy, sculpture and cabinetry. Chang enjoyed knitting. They both liked to travel and spend time at their house on the Chesapeake Bay where Bollum kept an eye on the wildlife and the heavens with his collection of telescopes and binoculars.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

In memoriam: David Baltimore
Courtney Chandler
In memoriam: Stuart A. Kornfeld
Jeyashree Alagarsamy
2025 PROLAB awardees announced
Marissa Locke Rottinghaus

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.

Bibel named assistant professor
Member News

Bibel named assistant professor

Nov. 24, 2025

She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

Cotruvo named Blavatnik award finalist
Member News

Cotruvo named Blavatnik award finalist

Nov. 17, 2025

He received a $15,000 prize and was honored at a gala in October.

Phosphatases and pupils: A dual legacy
Profile

Phosphatases and pupils: A dual legacy

Nov. 13, 2025

Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.